This was originally published by News Medical Life Sciences By combining genomic testing and next generation sequencing technology, a new...Continue Reading
DREAMM 7 – A Multicentre, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belnatamab mafadotin...Continue Reading
This post was originally published by Cure Specific disease characteristics of, and treatments for, multiple myeloma were not associated with...Continue Reading
This post was originally published by Targeted Oncology C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at...Continue Reading
Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.
